ARLINGTON, Va., Oct. 19, 2016 -- Willis Towers Watson (NASDAQ:WLTW), a leading global advisory, broking and solutions company, announced today that it will participate in the CG/LA 8th North American Infrastructure Leadership Forum, October 24 – 27 in Denver, CO.
The forum is focused on developing infrastructure in the U.S., Canada and Mexico while connecting business relationships and promoting public-private partnership (P3) projects across the region.
“Willis Towers Watson recognizes the growing importance of P3s around the world as they become the preeminent means of procuring economic and social infrastructure by the public sector,” said Paul Becker, global industry leader, Construction practice, Willis Towers Watson. “However, these public-private construction partnerships can lead to complex risks; therefore, there is a strong demand for innovative and forward-thinking risk management and insurance solutions to drive successful project outcomes.”
As part of the event, Willis Towers Watson executives will participate in and moderate a range of thought leadership discussions and debates on critical issues fundamental to building great infrastructure, including:
Building the Market, Introductory Keynote: Paul Becker, Global Industry Leader, Construction practice, Willis Towers Watson
World Economic Forum: Bringing the Private and Public Sectors Together to Build a Competitive U.S. Economy: Jessica Rasulo, Senior Vice President, Construction practice, Willis Towers Watson
Top P3 Projects: Chet Mitrani, Executive Vice President, Construction practice, Willis Towers Watson
“We’re proud to partner with CG/LA and serve as the sole risk advisor at the forum. We are committed to delivering innovative risk management solutions to support the growth of the P3 marketplace,” Becker added.
Additional information can be found on the event website. Interested individuals can follow Willis Towers Watson’s coverage of the conference via Twitter @WTWrisk and on the Willis Towers Watson blog.
About Willis Towers Watson
Willis Towers Watson (NASDAQ:WLTW) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has 39,000 employees in more than 120 countries. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com.
Media contact Colleen McCarthy: +1 212 915 8307 [email protected]


FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



